San Antonio, Texas
Phase 1 colorectal cancer trials in San Antonio, TX
43 Phase 1 colorectal cancer studies are recruiting participants at sites in San Antonio as of November 17, 2026, according to ClinicalTrials.gov. Colorectal Phase 1 Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
San Antonio at a glance
- 43 studies are recruiting at a site in San Antonio.
- By phase: Phase 1 (26), Phase 1/2 (17).
- By sponsor: industry (41), university, hospital or other (2).
- Most recent update to one of these records: November 17, 2026.
Studies recruiting in San Antonio
Basic details from each study's public record (the 30 most recently updated of 43). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Institut de Recherches Internationales Servier
- Study site
- START San Antonio
- Registry record
- NCT05786924 · updated
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
- Phase 1/2
- Ages 18 to 75
- All sexes
- Sponsor
- Tyligand Pharmaceuticals (Suzhou) Limited
- Study site
- NEXT Oncology
- Registry record
- NCT06385925 · updated
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Astellas Pharma Global Development, Inc.
- Study site
- START San Antonio (STSA)
- Registry record
- NCT07488676 · updated
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Vividion Therapeutics, Inc.
- Study site
- START San Antonio
- Registry record
- NCT06004245 · updated
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pliant Therapeutics, Inc.
- Study site
- UT Health San Antonio's Mays Cancer Center
- Registry record
- NCT06270706 · updated
A Phase 1 Dose Escalation and Dose Expansion Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kestrel Therapeutics, Inc.
- Study site
- NEXT Oncology
- Registry record
- NCT07458347 · updated
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- IDEAYA Biosciences
- Study sites
- NEXT Texas LLC - San Antonio · START San Antonio, LLC
- Registry record
- NCT07503808 · updated
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pfizer
- Study site
- START San Antonio
- Registry record
- NCT07318805 · updated
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- NEXT Oncology
- Registry record
- NCT07397338 · updated
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- NEXT Oncology
- Registry record
- NCT06720987 · updated
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Kumquat Biosciences Inc.
- Study site
- START San Antonio
- Registry record
- NCT07542704 · updated
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Alterome Therapeutics, Inc.
- Registry record
- NCT06835569 · updated
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- SHY Therapeutics
- Study site
- NEXT Oncology
- Registry record
- NCT07705334 · updated
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- GlaxoSmithKline
- Study site
- GSK Investigational Site
- Registry record
- NCT06885034 · updated
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- ModeX Therapeutics, An OPKO Health Company
- Study site
- NEXT Oncology
- Registry record
- NCT06239194 · updated
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Arvinas Inc.
- Registry record
- NCT07749586 · updated
FOG-001 in Locally Advanced or Metastatic Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Parabilis Medicines, Inc.
- Study site
- South Texas Accelerated Research Therapeutics, LLC
- Registry record
- NCT05919264 · updated
A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Bayer
- Study site
- START | San Antonio
- Registry record
- NCT07535112 · updated
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Phase 1/2
- Ages 12 and older
- All sexes
- Sponsor
- PMV Pharmaceuticals, Inc
- Study site
- New Experimental Therapeutics of San Antonio - NEXT Oncology
- Registry record
- NCT04585750 · updated
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
- Study site
- University of Texas San Antonio (UTSA)
- Registry record
- NCT06625775 · updated
A Study of PHN-012 in Patients With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Pheon Therapeutics
- Study site
- PHN-012-001 Site
- Registry record
- NCT07127874 · updated
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study sites
- NEXT Oncology San Antonio · START Texas
- Registry record
- NCT06128551 · updated
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Revolution Medicines, Inc.
- Study site
- START - San Antonio
- Registry record
- NCT07349537 · updated
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Angiex, Inc.
- Study site
- NEXT Oncology
- Registry record
- NCT06440005 · updated
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Sutro Biopharma, Inc.
- Study site
- NEXT San Antonio
- Registry record
- NCT07227168 · updated
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Cartography Biosciences
- Study site
- NEXT Oncology
- Registry record
- NCT07321106 · updated
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Marengo Therapeutics, Inc.
- Study site
- UT Health Mays Cancer Center
- Registry record
- NCT05592626 · updated
IDOV-Immune for Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- ViroMissile, Inc.
- Study site
- South Texas Accelerated Research Therapeutics
- Registry record
- NCT06910657 · updated
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Amgen
- Study site
- Next Oncology
- Registry record
- NCT07094113 · updated
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- Seagen, a wholly owned subsidiary of Pfizer
- Study site
- South Texas Accelerated Research Therapeutics, LLC
- Registry record
- NCT06131840 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in San Antonio, TX on ClinicalTrials.gov.
Ask about studies near San Antonio
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Texas
All Texas locations
119 studies recruiting across 18 cities.
Houston
86 studies recruiting.
Dallas
30 studies recruiting.
Irving
15 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that are in Phase 1, including early Phase 1 and combined Phase 1/2, as each study is coded in the registry.
Colorectal Phase 1 Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections